EUVIMEDEUVIMED entdecken
Crossref

Negative Second PET ‐ CT 1 Year After Treatment of Oropharyngeal Cancer Predicts Low Mortality and Recurrence

Nir Livneh iD, Chen Weinstein Wexler, Gilad Feinmesser, Iris Granot, Eran Alon

Clinical Otolaryngology · 2025-11 · 50 (6) · 973-980

DOI: 10.1111/coa.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Otolaryngology, online erschienen am 22.06.2025. Verfasst von Nir Livneh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Oropharyngeal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the prediction value of a second PET‐CT imaging study performed 1 year after treatment for patients with oropharyngeal carcinoma.

Methods

A Retrospective single‐institution tertiary care centre study. Included are all patients diagnosed with oropharyngeal cancer between 2010 and 2020 at a tertiary medical centre. All 77 suitable patients completed at least two ET‐CT scans during the post‐treatment period, the first at 3 months and the second at 1 year. The follow‐up extended to 5 years after treatment. The main outcome measures were overall survival (OS) and disease‐free survival (DFS).

Results

In total, 55 (65%) patients had no evidence of disease (NED) on the 1‐year PET‐CT. The negative predictive value of 1‐year PET‐CT was 91% for 4‐year DFS and 100% for 4‐year OS. Regression analysis of NED on the 1‐year PET‐CT correlated with 5‐year DFS (odds ratio [OR] 55, 95% confidence interval [CI] 5.2–500, p = 0.001) and low probability of 5‐year recurrence rates (OR 11.23, 1.23–100, p = 0.03).

Conclusions

The findings of this study demonstrate that NED on PET‐CT performed 1 year after the completion of treatment for oropharyngeal cancer is indicative of very low recurrence rates and almost non‐existent mortality. We suggest performing a second PET‐CT study at 1 year post‐treatment on all patients with negative results on the first one performed at 3 months post‐treatment. Negative findings on the second study may allow for a more lenient clinical follow‐up protocol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyOropharyngeal NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSurvival RateAdultAged, 80 and overPredictive Value of TestsFollow-Up StudiesTime FactorsPrognosis

Stichwörter der Autor:innen

PET‐CThuman papilloma virusoropharyngeal carcinomaprognosissurvival

Autor:innen und Institutionen

  • Department of Otolaryngology Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel.
  • Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel.

ORCID-Profile: Nir Livneh

Zitieren

APA

Livneh, N., Weinstein Wexler, C., Feinmesser, G., Granot, I., & Alon, E. (2025). Negative Second PET ‐ CT 1 Year After Treatment of Oropharyngeal Cancer Predicts Low Mortality and Recurrence. Clinical Otolaryngology, 50(6), 973-980. https://doi.org/10.1111/coa.70003

Vancouver

Livneh N, Weinstein Wexler C, Feinmesser G, Granot I, Alon E. Negative Second PET ‐ CT 1 Year After Treatment of Oropharyngeal Cancer Predicts Low Mortality and Recurrence. Clinical Otolaryngology. 2025;50(6):973-980. doi:10.1111/coa.70003

BibTeX
@article{Livneh2025,
  author = {Livneh, Nir and Weinstein Wexler, Chen and Feinmesser, Gilad and Granot, Iris and Alon, Eran},
  title = {Negative Second PET ‐ CT 1 Year After Treatment of Oropharyngeal Cancer Predicts Low Mortality and Recurrence},
  journal = {Clinical Otolaryngology},
  year = {2025},
  volume = {50},
  number = {6},
  pages = {973--980},
  doi = {10.1111/coa.70003}
}
Kostenlos starten →